NUWE (Nuwellis Corp) Total Debt to Capital

Public company logo of CHF Solutions (NUWE)

Nuwellis, Inc. (NUWE) minimizes medical risks by developing systems for removing excess fluid in patients with kidney and heart failure. The company's revenue is based on the sale of Aquadex blood ultrafiltration systems. Management is currently focused on internal restructuring, B2B partnerships, and selling software to clinics. The dynamics of the debt-to-equity ratio stand at 0.00, which is clearly demonstrated by the price chart on the GURU.Markets platform.

NUWE: Nuwellis Debt to Capital 07/04/2022 - 11/02/2026

Analytical breakdowns and data insights for company Nuwellis Corp (NUWE)

- stock quotes and analyst forecast:
Stock Quotes Nuwellis|NUWE - Analyst Forecast Prices
- business market valuation indicators:
Market Capitalization Nuwellis|NUWE - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share Nuwellis|NUWE - Total Stockholders' Equity|Market Value to Book Value Ratio nuwellis.com|NUWE - Aggregate Asset Value
- company total debt and liquidity indicators:
Total Debt to Capital Nuwellis, Inc.|NUWE - Long-Term Debt to Capital|Short-Term Debt to Equity Nuwellis, Inc.|NUWE - Company Aggregate Indebtedness|Debts to Book Capitalization Nuwellis|NUWE - Long-Term Debt|Company Current Liabilities Nuwellis|Quick Liquidity Indicator nuwellis.com
- earnings and valuation multiples information:
NUWE - Profit After Payment of Taxes
Summary company analytics:Nuwellis, NUWE
Finished products of Nuwellis, Inc.

The integration of Inertia devices into US intensive care units creates a steady revenue stream from consumables, which determines the ability of Nuwellis, Inc. (NUWE) to service its obligations. The dynamics of the total debt-to-equity ratio reflect the proportion of borrowed funds to net assets, allowing investors to assess financial stability and the risk of capital impairment should credit conditions change.

Competitors of Nuwellis, Inc.

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|Senseonics Corp - Aggregate Debt to Equity|Total Debt to Capital NPCE|TCMD - Debt to Capital|SANUWAVE Health, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Outset Medical Corp OM|ELMD: Total Debt to Equity Ratio|lensar.com - Aggregate Debt to Capital|RCEL: Total Debt to Capital|PROF - Total Debt to Capital Coefficient|BDMD (Baird Medical Investment Holdings) - Total Debt to Capital|Total Debt to Equity Ratio EDAP Medical (EDAP)|Total Debt to Equity Ratio APYX (Apyx Medical)|ICCM (icecure-medical.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Pulmonx LUNG|TELA - Total Debt to Equity Ratio|CytoSorbents Corp. - Total Debt to Capital|Debt to Capital Sensus|ZYXI: Total Debt to Capital|Debt to Equity Ratio ECOR|RBOT (Vicarious Surgical Inc) - Total Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Total Debt to Capital Coefficient|Total Debt to Capital ICU|Total Debt to Equity Ratio iridex.com IRIX|Total Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Total Debt to Capital Beyond Air Inc XAIR|PFSA - Debt to Equity|SSKN: Debt to Equity|GCTK (GlucoTrack) - Total Debt to Equity Ratio|NanoVibronix Inc. - All Debt to Shareholders' Equity Ratio|VERO (Venus Concept Inc.) - Total Debt to Capital|Debt to Capital aethlonmedical.com AEMD|Debt to Equity Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Debt to Capital Ratio|BioSig Technologies, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.